NCCC Meeting 9 Agenda

Time	Session
1:00 pm – 1:10 pm	Welcome, roll call, and review of the agenda Clydette Powell, MD, MPH, FAAP Designated Federal Officer, NCCC Office on Women's Health Office of the Assistant Secretary for Health U.S. Department of Health and Human Services William H. Herman, MD, MPH Chair, National Clinical Care Commission
1:10 pm – 2:10 pm	Treatment and Complications Subcommittee Update Paul Conlin, MD Veterans Affairs Boston Healthcare System Carol Greenlee, MD, FACP, FACE Western Slope Endocrinology Summary from stakeholder organization calls Presentation and Discussion of revised recommendations from September 2020 meeting Presentation and discussion of NEW recommendations
2:10 pm – 3:10 pm	Prevention – Targeted Population Subcommittee Update John Boltri, MD, FAAFP Northeast Ohio Medical University College of Medicine Ann Albright, PhD, RDN Centers for Disease Control and Prevention Summary from stakeholder organization calls Presentation and Discussion of revised recommendations from September 2020 meeting Presentation and discussion of NEW recommendations
3:10 pm – 3:25 pm	Break
3:25 pm – 4:25 pm	Prevention – General Population Subcommittee Update Dean Schillinger, MD San Francisco General Hospital Ann Bullock, MD Indian Health Service Summary from stakeholder organization calls Presentation and Discussion of revised recommendations from September 2020 meeting Presentation and discussion of NEW recommendations
4:25 pm – 4:55 pm	Health Systems Organization Discussion William H. Herman, MD, MPH Chair, National Clinical Care Commission
4:55 pm – 5:10 pm	Oral Public Comments
5:10 pm – 5:13 pm	Public Comment Solicitation Clydette Powell, MD, MPH, FAAP Designated Federal Officer, NCCC
5:13 pm – 5:15 pm	Recognition and Appreciation of Service to NCCC William H. Herman, MD, MPH Chair, National Clinical Care Commission
5:15 pm – 5:25 pm	Meeting Review and Next Steps William H. Herman, MD, MPH Chair, National Clinical Care Commission
5:30 pm	Adjournment